Partial mu-opioid receptor agonist with behavioral intervention
This page covers all Partial mu-opioid receptor agonist with behavioral intervention drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Mu-opioid receptor (OPRM1).
Targets
Phase 3 pipeline (1)
- Buprenorphine +CHC · Friends Research Institute, Inc. · Psychiatry / Addiction Medicine
Buprenorphine is a partial mu-opioid receptor agonist combined with a contingency management component (CHC) to treat opioid use disorder through both pharmacological and behavioral intervention.
Patent intelligence
- partial mu opioid receptor agonist with behavioral intervention patent landscape — aggregated cliff calendar, attackable patents, originator estates